NXHSF Financial Statements & Analysis
Complete financial statements for NXHSF including income statement, balance sheet, and cash flow statement. Analyze NXHSF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
150.9% ↑
Net Income
47.6% ↑
Gross Margin
191.3% ↑
Operating Margin
78.8% ↑
Balance Sheet
Current Ratio
118.1% ↑
Debt to Equity
120.2% ↓
Asset Turnover
34.0% ↑
Cash Flow
Operating Cash Flow
27.1% ↑
Net Cash Flow
306.0% ↑
Free Cash Flow
17.9% ↑
Cash Flow to Debt
59.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 1.36M | 3.42M | 150.9% | |
| Gross Profit | -334.35K | 766.16K | 329.1% | |
| Operating Income | -14.65M | -7.79M | 46.8% | |
| Net Income | -14.60M | -7.65M | 47.6% | |
| EPS | -0.64 | -0.31 | 51.6% | |
| EBITDA | -13.46M | -6.71M | 50.2% | |
| Gross Margin | -24.54% | 22.41% | 191.3% | |
| Operating Margin | -1075.21% | -227.84% | 78.8% | |
| Net Income Margin | -1071.53% | -223.70% | 79.1% | |
| R&D Expenses | 8.63M | 4.79M | 44.6% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.42M | 1.36M | 951.91K | — | — |
| Gross Profit | 766.16K | -334.35K | -288.79K | — | — |
| Operating Income | -7.79M | -14.65M | -12.49M | — | — |
| Net Income | -7.65M | -14.60M | -12.01M | — | — |
| EPS | -0.31 | -0.64 | -0.52 | — | — |
| EBITDA | -6.71M | -13.46M | -10.91M | — | — |
| Gross Margin | 22.41% | -24.54% | -30.34% | — | — |
| Operating Margin | -227.84% | -1075.21% | -1312.46% | — | — |
| Net Income Margin | -223.70% | -1071.53% | -1262.09% | — | — |
| R&D Expenses | 4.79M | 8.63M | 7.07M | — | — |
Financial Metrics
Want to dive deeper into NXHSF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics